As a Free StocksGuide user, you can view scores for all 7,008 stocks worldwide.
10 Analysts have issued a ITeos Therapeutics Inc forecast:
10 Analysts have issued a ITeos Therapeutics Inc forecast:
Jun '25 |
+/-
%
|
||
Revenue | - - |
-
|
|
Gross Profit | - - |
-
|
|
EBITDA | -164 -164 |
14%
14%
|
EBIT (Operating Income) EBIT | -166 -166 |
14%
14%
|
Net Profit | -168 -168 |
55%
55%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
iTeos Therapeutics, Inc. engages in the development of biopharmaceuticals therapeutic products and services. It offers immuno-oncology therapeutics for patients. The company was founded by Michel Detheux in April 2012 and is headquartered in Cambridge, MA.
Head office | United States |
CEO | Michel Detheux |
Employees | 173 |
Founded | 2012 |
Website | www.iteostherapeutics.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.